<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Advanced Medical Solutions Group Plc — News on 6ix</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc</link>
<description>Latest news and press releases for Advanced Medical Solutions Group Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 09:02:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/advanced-medical-solutions-group-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d57891beedb30cb6f87d5e.webp</url>
<title>Advanced Medical Solutions Group Plc</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc</link>
</image>
<item>
<title>Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 28 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-28-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-28-04-2026-cgwl</guid>
<pubDate>Wed, 29 Apr 2026 09:02:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 27 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-27-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-27-04-2026-cgwl</guid>
<pubDate>Tue, 28 Apr 2026 08:20:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 24 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-24-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-24-04-2026-cgwl</guid>
<pubDate>Mon, 27 Apr 2026 08:18:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 24 04 2026] - (CGAM)</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-24-04-2026-cgam</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-24-04-2026-cgam</guid>
<pubDate>Mon, 27 Apr 2026 08:16:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiarie</description>
</item>
<item>
<title>Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 23 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-23-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-23-04-2026-cgwl</guid>
<pubDate>Fri, 24 Apr 2026 08:42:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 22 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-22-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-22-04-2026-cgwl</guid>
<pubDate>Thu, 23 Apr 2026 08:32:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - Advanced Medical Solutions Group</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-group-1</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-group-1</guid>
<pubDate>Wed, 22 Apr 2026 13:04:00 GMT</pubDate>
<description>8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation</description>
</item>
<item>
<title>Form 8.5 (EPT/RI) - Advanced Medical Solutions Group plc</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-85-eptri-advanced-medical-solutions-group-plc-1</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-85-eptri-advanced-medical-solutions-group-plc-1</guid>
<pubDate>Wed, 22 Apr 2026 10:19:00 GMT</pubDate>
<description>FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeAdvanced Medical Solutions Group Plc(c) Name of the party to the offer with which exempt principal trader</description>
</item>
<item>
<title>Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 21 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-21-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-21-04-2026-cgwl</guid>
<pubDate>Wed, 22 Apr 2026 09:05:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 20 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-20-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-20-04-2026-cgwl</guid>
<pubDate>Tue, 21 Apr 2026 08:15:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - Opening Disclosure - 20 04 2026] - (CGAML)</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-opening-disclosure-20-04-2026-cgaml</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-plc-opening-disclosure-20-04-2026-cgaml</guid>
<pubDate>Tue, 21 Apr 2026 08:08:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiarie</description>
</item>
<item>
<title>Dimensional Fund Advisors Ltd. : Form 8.3 - ADVANCED MEDICAL SOLUTIONS - Ordinary Shares</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/dimensional-fund-advisors-ltd-form-83-advanced-medical-solutions-ordinary-shares</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/dimensional-fund-advisors-ltd-form-83-advanced-medical-solutions-ordinary-shares</guid>
<pubDate>Tue, 21 Apr 2026 07:50:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of discloser:Dimensional Fund Advisors Ltd. whose parent is Dimensional Fund Advisors LP, and also on behalf their investment advisory affiliates (“Dimensional”). The Dimensional entities are investment advisors and Dimensional expressly disclaims beneficial ownership of the shares describe</description>
</item>
<item>
<title>Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-group-plc-octopus-investments</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/form-83-advanced-medical-solutions-group-plc-octopus-investments</guid>
<pubDate>Mon, 20 Apr 2026 13:50:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:OCTOPUS INVESTMENTS LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree i</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/holdings-in-company-1175</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/holdings-in-company-1175</guid>
<pubDate>Wed, 08 Apr 2026 17:13:00 GMT</pubDate>
<description>Lombard Odier Asset Management (Europe) Limited has acquired a new holding in Advanced Medical Solutions Group PLC, crossing a notification threshold on April 7, 2026. The firm now holds 11,297,046 voting rights, representing 5.14% of the total voting rights. This notification is for an acquisition of voting rights, and Lombard Odier Asset Management (Europe) Limited is not controlled by any other entity.
Disclaimer*</description>
</item>
<item>
<title>Total Voting Rights</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/total-voting-rights-882</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/total-voting-rights-882</guid>
<pubDate>Tue, 31 Mar 2026 17:17:00 GMT</pubDate>
<description>Advanced Medical Solutions Group plc has announced that as of 31 March 2026, its total issued share capital comprises 219,604,175 ordinary shares of 5p each, all of which carry voting rights and none are held in treasury. This figure serves as the denominator for shareholders to determine if they need to notify any changes to their interest in the company under the FCA's Disclosure and Transparency Rules.
Disclaimer*</description>
</item>
<item>
<title>Unaudited Preliminary Results</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/unaudited-preliminary-results-13</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/unaudited-preliminary-results-13</guid>
<pubDate>Wed, 18 Mar 2026 07:00:00 GMT</pubDate>
<description>Advanced Medical Solutions Group plc reported record full-year sales of £228.9 million for the year ended 31 December 2025, a 29% increase driven by strong organic growth and the full-year impact of the Peters Surgical acquisition. Adjusted EBITDA rose by 24% to £49.9 million, while reported profit before tax significantly increased by 81% to £17.8 million. The company also saw a reduction in net debt to £50.5 million and proposed a 10% increase in its full-year dividend to 2.86p per share, refl</description>
</item>
<item>
<title>Block listing Interim Review</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/block-listing-interim-review-317</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/block-listing-interim-review-317</guid>
<pubDate>Fri, 06 Mar 2026 07:00:00 GMT</pubDate>
<description>Advanced Medical Solutions Group plc has provided an update on its block admission arrangements for various share schemes, including the Employee Share Purchase Plan, Group Share Option Plan, and others. Between September 6, 2025, and March 5, 2026, the company increased its block schemes by a total of 10,400,000 ordinary shares, while issuing 1,856,229 shares under these schemes. The remaining unallotted securities across all schemes at the end of the period total 6,502,313 ordinary shares. The</description>
</item>
<item>
<title>Full Year 2025 Trading Update</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/full-year-2025-trading-update-6</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/full-year-2025-trading-update-6</guid>
<pubDate>Thu, 15 Jan 2026 07:00:00 GMT</pubDate>
<description>Advanced Medical Solutions Group plc expects to report full year 2025 revenues of approximately £228.5 million, a significant increase from £177.5 million in 2024, with EBITDA projected between £49.5 million and £50.0 million, up from £40.2 million in the prior year. This strong growth, driven by key surgical product categories and a recovery in Woundcare, is in line with market expectations. The integration of Peters Surgical and Syntacoll is progressing well, with commercial synergies already </description>
</item>
<item>
<title>Upcoming Investor Conferences</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/upcoming-investor-conferences-2</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/upcoming-investor-conferences-2</guid>
<pubDate>Mon, 27 Oct 2025 07:00:00 GMT</pubDate>
<description>Advanced Medical Solutions Group plc will participate in investor conferences in November and December. The first conference is the Investec UK CEO Conference in London on November 11, 2025, involving one-on-one and group investor meetings. The second is the Berenberg European Conference in Windsor on December 4, 2025, also featuring one-on-one and group investor meetings.
Disclaimer*</description>
</item>
<item>
<title>Director/PDMR Shareholding</title>
<link>https://6ix.com/company/advanced-medical-solutions-group-plc/news/directorpdmr-shareholding-1063</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-medical-solutions-group-plc/news/directorpdmr-shareholding-1063</guid>
<pubDate>Wed, 08 Oct 2025 15:14:00 GMT</pubDate>
<description>On October 7, 2025, Advanced Medical Solutions Group plc announced that Eddie Johnson, a Director and PDMR, executed share transactions on October 6, 2025, involving 18,726 ordinary shares of 5p. Specifically, 18,726 shares were sold at 219.98p per share. Simultaneously, Mr. Johnson repurchased 9,546 shares at 219.90p each and his wife, Jackie Johnson, repurchased 9,040 shares at 221.10p each through Individual Savings Accounts. Following these transactions, Eddie Johnson and related parties now</description>
</item>
</channel>
</rss>